Real-Life Chronic Rhinosinusitis Outcome Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChange Accelerator in Respiratory Care

About this trial

An international consortium of leading medical experts in the field of chronic respiratory disease, the research team of Galenus Health and the non-profit organization EUFOREA (European Forum for Research and Education in Allergy and Airway diseases) has been conceived to conduct real-life outcome research. The Galenus Health digital platform consisting of a mobile application for patients and an online dashboard for physicians will be implemented in each of the participating centres. The data will be centralized in a pseudonymized database and will be the basis of the Chronic RhinoSinusitis Outcome Registry.

Eligibility criteria

Qualifiers

Physician diagnosis of Chronic RhinoSinusitis

Capable of using a mobile application on a smartphone

Disqualifiers

Patients with malignancies of the sinonasal cavity

Patients with inverted papilloma

Patients with unilateral disease

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

4,550 Participants
are grouped into 1 trial group